<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Publications | Vllasaliu Lab</title>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<link rel="stylesheet" href="style.css">
</head>

<body>

<header>
  <div class="nav">
    <div><strong>Vllasaliu Lab</strong></div>
    <div class="nav-links">
      <a href="index.html">Home</a>
      <a href="research.html">Research</a>
      <a href="people.html">People</a>
      <a href="publications.html">Publications</a>
      <a href="join.html">Join Us</a>
      <a href="contact.html">Contact</a>
    </div>
  </div>
</header>

<div class="container">

<h1>Publications</h1>

<h2>2025</h2>

<p>
Ding, A, Daci, A., Krasniqi, V., Butler, R., Goddard, A., 
Guo, Q., Zhang, Y., Zhong, Z. J., Chan, A., Thanou, M. & 
<strong>Vllasaliu, D.</strong> (2025).  
Engineered extracellular vesicles demonstrate altered endocytosis 
and biodistribution and have superior oral siRNA delivery efficiency 
compared to lipid nanoparticles.  
<em>International Journal of Pharmaceutics: X</em>, 10, 100428.
</p>

<p>
Xu, X., Zan, B., Xie, Y., Akapan, P., da Silva, M., Zhao, M., 
Hasan, E., Rakovich, A., <strong>Vllasaliu, D.</strong>, Smith, G. N., 
González‐Gaitano, G., Hogarth, G. & Dreiss, C. A. (2025).  
Self‐Assembled Polypseudorotaxanes Crosslinked by Dynamic Disulfide Bonds 
as Modular Functionalization for Thiophilic Metal Nanoparticles.  
<em>Angewandte Chemie International Edition</em>, 64(44), e202515585.
</p>

<p>
Feng, S., Raimi-Abraham, B. T. & <strong>Vllasaliu, D.</strong> (2025).  
PEG-PLGA nanoparticles transport across in vitro intestinal epithelial models 
and show potential for oral delivery of antibodies in inflammatory bowel disease.  
<em>Journal of Drug Delivery Science and Technology</em>, 108, 106925.
</p>

<p>
<strong>Vllasaliu, D.</strong> (2025).  
Grand challenges in oral drug delivery.  
<em>Frontiers in Drug Delivery</em>, 5, 1571982.
</p>

<p>
Javorovic, J., Hanafy, B. I., Franek, F. & <strong>Vllasaliu, D.</strong> (2025).  
Comparison of macromolecule permeation through extracellular matrix and 
hyaluronic acid to inform in vitro testing of subcutaneous therapies.  
<em>RSC Pharmaceutics</em>, 2(3), 624–629.
</p>

<p>
Zhang, L., Halket, J., Caldwell, A., <strong>Vllasaliu, D.</strong>, 
Bajka, B. & Dreiss, C. A. (2025).  
Controlling in vitro lipid digestion: Pickering emulsions with cellulose 
nanocrystals, chitosan and methylcellulose.  
<em>Food Research International</em>, 218, 116793.
</p>

<p>
Luo, C., Zhang, Y., Ding, A., Javorovic, J., Raimi-Abraham, B., 
Lynham, S., Yang, X., Shenker, N. & <strong>Vllasaliu, D.</strong> (2025).  
Mechanistic insight into human milk extracellular vesicle–intestinal barrier interactions.  
<em>Journal of Extracellular Biology</em>, 4(1), e70032.
</p>


<h2>2024</h2>

<p>
Somby, K., Campagna, V., Sánchez-Félix, M. V., Forbes, B. & 
<strong>Vllasaliu, D.</strong> (2024).  
Development of in vitro biopharmaceutics tools for predicting the 
bioavailability of subcutaneously injected monoclonal antibodies 
and oligonucleotides.  
<em>Expert Opinion on Drug Delivery</em>, 21(9), 1307–1310.
</p>

<p>
Bannunah, A. M., Cavanagh, R., Ahubber, S., 
<strong>Vllasaliu, D.</strong> & Stolnik, S. (2024).  
Difference in endocytosis pathways used by differentiated versus 
nondifferentiated epithelial Caco-2 cells to internalize nanosized particles.  
<em>Molecular Pharmaceutics</em>, 21(7), 3603–3612.
</p>

<p>
Wu, L., <strong>Vllasaliu, D.</strong>, Cui, Q. & Raimi-Abraham, B. (2024).  
In situ self-assembling liver spheroids with synthetic nanoscaffolds 
for preclinical drug screening applications.  
<em>ACS Applied Materials & Interfaces</em>, 16(20), 25610–25621.
</p>

<p>
Belaid, M., Javorovic, J., Pastorin, G. & 
<strong>Vllasaliu, D.</strong> (2024).  
Development of an in vitro co-culture model using Caco-2 and J774A.1 
cells to mimic intestinal inflammation.  
<em>European Journal of Pharmaceutics and Biopharmaceutics</em>, 197, 114243.
</p>

<p>
Zhang, Y., Luo, C., Belaid, M., Thanou, M. & 
<strong>Vllasaliu, D.</strong> (2024).  
Hybrid milk extracellular vesicles as potential systems for oral delivery of siRNA.  
<em>Advanced Therapeutics</em>, 7(3), 2300335.
</p>

<footer>
© 2026 Vllasaliu Lab | King’s College London
</footer>

</div>

</body>
</html>
